Your browser doesn't support javascript.
loading
Methylation of STK11 promoter is a risk factor for tumor stage and survival in clear cell renal cell carcinoma.
Zheng, Fufu; Yuan, Xiaoxu; Chen, Enjing; Ye, Yunlin; Li, Xiaofei; Dai, Yuping.
Afiliación
  • Zheng F; Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R. China.
  • Yuan X; Department of Urology, Jiangmen Central Hospital, Jiangmen, Guangdong 529030, P.R. China.
  • Chen E; Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R. China.
  • Ye Y; Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P.R. China.
  • Li X; Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R. China.
  • Dai Y; Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, P.R. China.
Oncol Lett ; 14(3): 3065-3070, 2017 Sep.
Article en En | MEDLINE | ID: mdl-28927054
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncol Lett Año: 2017 Tipo del documento: Article Pais de publicación: Grecia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncol Lett Año: 2017 Tipo del documento: Article Pais de publicación: Grecia